2025

Phanthaphol, Nattaporn, Somboonpatarakun, Chalermchai, Suwanchiwasiri, Kwanpirom, Yuti, Pornpimon, Sujjitjoon, Jatuporn, Augsornworawat, Punn, Baillie, George S. ORCID: https://orcid.org/0000-0003-2469-6316, Junking, Mutita and Yenchitsomanus, Pa-thai (2025) Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFv. Journal of Translational Medicine, 23, 451. (doi: 10.1186/s12967-025-06453-y) (PMID:40241132) (PMCID:PMC12004729)

2024

Chiawpanit, Chutipa, Wathikthinnakorn, Methi, Sawasdee, Nunghathai, Phanthaphol, Nattaporn, Sujjitjoon, Jatuporn, Junking, Mutita, Yamabhai, Montarop, Panaampon, Jutatip, Yenchitsomanus, Pa-Thai and Panya, Aussara (2024) Precision immunotherapy for cholangiocarcinoma: pioneering the use of human-derived anti-cMET single chain variable fragment in anti-cMET chimeric antigen receptor (CAR) NK cells. International Immunopharmacology, 136, 112273. (doi: 10.1016/j.intimp.2024.112273) (PMID:38810311)

Cooke, S. F. et al. (2024) Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC. Scientific Reports, 14, 8998. (doi: 10.1038/s41598-024-59451-3) (PMID:38637546) (PMCID:PMC11026450)

Somboonpatarakun, Chalermchai, Phanthaphol, Nattaporn, Suwanchiwasiri, Kwanpirom, Ramwarungkura, Boonyanuch, Yuti, Pornpimon, Poungvarin, Naravat, Thuwajit, Peti, Junking, Mutita and Yenchitsomanus, Pa-Thai (2024) Cytotoxicity of fourth-generation anti-Trop2 CAR-T cells against breast cancer. International Immunopharmacology, 129, 111631. (doi: 10.1016/j.intimp.2024.111631) (PMID:38359664)

Articles

Phanthaphol, Nattaporn, Somboonpatarakun, Chalermchai, Suwanchiwasiri, Kwanpirom, Yuti, Pornpimon, Sujjitjoon, Jatuporn, Augsornworawat, Punn, Baillie, George S. ORCID: https://orcid.org/0000-0003-2469-6316, Junking, Mutita and Yenchitsomanus, Pa-thai (2025) Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFv. Journal of Translational Medicine, 23, 451. (doi: 10.1186/s12967-025-06453-y) (PMID:40241132) (PMCID:PMC12004729)

Chiawpanit, Chutipa, Wathikthinnakorn, Methi, Sawasdee, Nunghathai, Phanthaphol, Nattaporn, Sujjitjoon, Jatuporn, Junking, Mutita, Yamabhai, Montarop, Panaampon, Jutatip, Yenchitsomanus, Pa-Thai and Panya, Aussara (2024) Precision immunotherapy for cholangiocarcinoma: pioneering the use of human-derived anti-cMET single chain variable fragment in anti-cMET chimeric antigen receptor (CAR) NK cells. International Immunopharmacology, 136, 112273. (doi: 10.1016/j.intimp.2024.112273) (PMID:38810311)

Cooke, S. F. et al. (2024) Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC. Scientific Reports, 14, 8998. (doi: 10.1038/s41598-024-59451-3) (PMID:38637546) (PMCID:PMC11026450)

Somboonpatarakun, Chalermchai, Phanthaphol, Nattaporn, Suwanchiwasiri, Kwanpirom, Ramwarungkura, Boonyanuch, Yuti, Pornpimon, Poungvarin, Naravat, Thuwajit, Peti, Junking, Mutita and Yenchitsomanus, Pa-Thai (2024) Cytotoxicity of fourth-generation anti-Trop2 CAR-T cells against breast cancer. International Immunopharmacology, 129, 111631. (doi: 10.1016/j.intimp.2024.111631) (PMID:38359664)